Skip to main content

Table 1 Demographic and clinical data associated with fetal heart rate category

From: The impact of non-significant variable decelerations appearing in the latent phase on delivery mode: a prospective cohort study

 

Category I

Category II

Category II

pa

  

NSV

SV

 
 

(N = 251)

(N = 186)

(N = 76)

 

Maternal characteristics

    

Maternal age, years

29.7 ± 5.9

29.6 ± 5.6

29.6 ± 5.2

0.9

Body mass index, kg/m2

29.3 ± 4.5

29.2 ± 4.8

30.8 ± 5.3

0.05b

Gestational age, weeks

39.6 ± 1.2

39.4 ± 1.5

39.6 ± 1.3

0.5

Parity

2.6 ± 1.6

2.5 ± 1.5

2.3 ± 1.5

0.4

Primiparous vs Multiparous

   

0.05b

   Primiparous

72 (28.7)

56 (30.1)

33 (43.4)

 

   Multiparous

179 (71.3)

130 (69.9)

43 (56.6)

 

Maternal disease

20 (8.0)

39 (21.0)

14 (18.4)

0.0001c

Oligohydramnios

13 (5.2)

21 (11.7)

18 (23.7)

0.0001d

Polyhydramnios

6 (2.4)

4 (2.2)

2 (2.6)

1

Induction of labor

62 (24.7)

121 (65.1)

58 (76.3)

0.0001c

Epidural

61 (24.3)

61 (32.8)

32 (42.1)

0.0001c

Delivery method

   

0.0001b

Spontaneous Vaginal

238 (94.8)

166 (89.2)

40 (52.6)

 

Vacuum or cesarean

13 (5.2)

20 (10.8)

36 (47.4)

 

Vacuum

6 (2.4)

8 (4.3)

11 (14.5)

 

Cesarean

7 (2.8)

12 (6.5)

25 (32.9)

 

Reasons for vacuum or cesarean delivery

   

0.03b

   Non reassuring fetal heart rate monitoring

3 (23.1)

5 (25.0)

20 (55.6)

 

   Failure to progress in the active or second stage

10 (76.9)

15 (75.0)

16 (44.4)

 

Neonatal outcome

    

Neonatal weight, g

3329 ± 392

3297 ± 439

3130 ± 487

0.002b

Neonates born < 2500 g

2 (0.8)

7 (3.8)

9 (11.8)

0.0001e

Apgar score at 5 minutes

9.96 ± 0.23

9.90 ± 0.31

9.86 ± 0.39

0.01

Cord pH

7.31 ± 0.07

7.31 ± 0.07

7.30 ± 0.08

0.5

Cord pH between 7.0 and 7.1

2 (0.8)

1 (0.5%)

4 (5.3)

0.008b

Meconium stained amniotic fluid

22 (8.8)

26 (14.0)

15 (19.7)

0.03f

Nuchal cord or true knot

23 (9.2)

19 (10.2)

12 (15.8)

0.3

Neonatal deaths

0

0

0

1

  1. Data are mean ± standard deviation or n (%) unless otherwise specified.
  2. aComparison of all three groups; bCategory II-SV versus Category I and Category II-NSV; cCategory II-NSV and Category II-SV versus Category I; dCategory II-NSV versus Category I, p = 0.01, dCategory II-SV versus Category II-NSV, p = 0.02;
  3. eCategory II-NSV versus Category I, p = 0.04, eCategory II-SV versus Category II-NSV, p = 0.02; fCategory II-SV versus Category I.
  4. Abbreviations: NSV: non-significant variable decelerations (study group); SV: significant variable decelerations; NS: non-significant. Maternal disease: hypertensive disorders, gestational or pre-gestational diabetes, thrombophilia, cardiac disease and asthma.